2223-96-3 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 4-chloro-2-methylthio-5-pyrimidinecarboxylate is used as an intermediate for the synthesis of various drugs. Its unique chemical structure allows it to be a key component in the development of new pharmaceutical compounds, contributing to the advancement of medicine.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 4-chloro-2-methylthio-5-pyrimidinecarboxylate is used as a building block for the production of pesticides. Its incorporation into these products helps in the development of effective solutions for pest control, thereby supporting agricultural productivity.
Used in Herbicide Manufacturing:
Methyl 4-chloro-2-methylthio-5-pyrimidinecarboxylate is used as a key ingredient in the manufacturing of certain herbicides. Its presence in these formulations aids in the control of unwanted plant growth, ensuring healthier and more productive crops.
Used in Fungicide Production:
Methyl 4-chloro-2-Methylthio-5-pyriMidinecarboxylate also plays a crucial role in the production of fungicides. Its inclusion in these products helps in combating fungal infections in various crops, thus protecting them from diseases and enhancing overall yield.
Check Digit Verification of cas no
The CAS Registry Mumber 2223-96-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,2 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2223-96:
(6*2)+(5*2)+(4*2)+(3*3)+(2*9)+(1*6)=63
63 % 10 = 3
So 2223-96-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H11ClN2O2S/c1-3-14-8(13)6-5-11-9(15-4-2)12-7(6)10/h5H,3-4H2,1-2H3
2223-96-3Relevant academic research and scientific papers
Src kinase inhibitor compounds
-
, (2008/06/13)
Pyrimidine compounds (Formula I), or their pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers, and pharmaceutical compositions including the same, which are inhibitors of tyrosine kinase enzymes, and as such are useful in the prophylaxis and treatment of protein tyrosine kinase-associated disorders, such as immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to play a role, such as cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis and psoriasis.
